This inventor holds 4 USPTO granted patents. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2002-2011.
Company Filing History:
Years Active: 2002-2011
Title: Mathis Grossmann: Innovator in Human Glycoprotein Hormones
Introduction
Mathis Grossmann is a notable inventor based in Parkville, Australia. He has made significant contributions to the field of biochemistry, particularly in the development of human glycoprotein hormones. With a total of 4 patents to his name, Grossmann's work has the potential to impact medical science and therapeutic applications.
Latest Patents
Grossmann's latest patents include innovations related to human luteinizing hormone superagonists and human chorionic gonadotropin superagonists. The inventions focus on human glycoprotein hormones that possess specific amino acid modifications aimed at enhancing their activity. These modifications involve the introduction of basic amino acids at critical positions within the hormone structure. Additionally, the patents detail methods for constructing superactive nonchimeric analogs of human hormones by comparing amino acid sequences with more active homologs from other species. The inventions also encompass nucleic acids encoding these modified hormones, as well as vectors and host cells that facilitate their production.
Career Highlights
Mathis Grossmann is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this prestigious institution underscores his commitment to advancing scientific knowledge and improving health outcomes through innovative research.
Collaborations
Some of Grossmann's notable coworkers include Mariusz W Szkudlinski and Bruce D Weintraub. Their collaborative efforts contribute to the ongoing research and development in the field of glycoprotein hormones.
Conclusion
Mathis Grossmann's contributions to the field of human glycoprotein hormones exemplify the importance of innovation in medical research. His patents reflect a commitment to enhancing therapeutic options and advancing scientific understanding.